Evidence map›Paper›PMID 28620892›Full record

ArticleJournal of autism and developmental disorders2017

A Prospective Study of the Concordance of DSM-IV and DSM-5 Diagnostic Criteria for Autism Spectrum Disorder.

Micah O Mazurek, Frances Lu, Heather Symecko, Eric Butter, Nicole M Bing, Rachel J Hundley, Marie Poulsen, Stephen M Kanne, Eric A Macklin, Benjamin L Handen

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05916339 (Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder), which is not on this map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05916339 phase4recruitingnot on this mapstarted 2023, after this paper: background citation

Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder

TypeinterventionalSponsorDaniel CouryRan2023 to 2027Enrolled500ConditionsADHD, Autism Spectrum DisorderArmsRandomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Machine Learning Differentiation of Autism Spectrum Sub-Classifications.Journal of autism and developmental disorders · 2024
    Article
  7. The Impact of the Comorbidity of ASD and ADHD on Social Impairment.Journal of autism and developmental disorders · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Autism spectrum disorder.Lancet (London, England) · 2018
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Micah O MazurekDepartment of Health Psychology, Thompson Center for Autism and Neurodevelopmental Disorders, University of Missouri, 205 Portland Street, Columbia, MO, 65211, USA. mazurekm@missouri.edu.ORCID http://orcid.org/0000-0001-7715-6538
Frances LuBiostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Heather SymeckoBiostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Eric ButterDepartment of Pediatrics and Psychology, Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
Nicole M BingDivision of Developmental and Behavioral Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Rachel J HundleyDivision of Developmental Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Marie PoulsenDepartment of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Stephen M KanneDepartment of Health Psychology, Thompson Center for Autism and Neurodevelopmental Disorders, University of Missouri, 205 Portland Street, Columbia, MO, 65211, USA.
Eric A MacklinBiostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Benjamin L HandenDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transition from DSM-IV to DSM-5 criteria for autism spectrum disorder (ASD) sparked considerable concern about the potential implications of these changes. This study was designed to address limitations of prior studies by prospectively examining the concordance of DSM-IV and final DSM-5 criteria on a consecutive sample of 439 children referred for autism diagnostic evaluations. Concordance and discordance were assessed using a consistent diagnostic battery. DSM-5 criteria demonstrated excellent overall specificity and good sensitivity relative to DSM-IV criteria. Sensitivity and specificity were strongest for children meeting DSM-IV criteria for autistic disorder, but poor for those meeting criteria for Asperger's disorder and pervasive developmental disorder. Higher IQ, older age, female sex, and less pronounced ASD symptoms were associated with greater discordance.

Indexed as

Diagnostic and Statistical Manual of Mental DisordersAdolescentAge FactorsAsperger SyndromeAutism Spectrum DisorderAutistic DisorderChildChild Development Disorders, PervasiveFemaleHumansIntelligenceMaleProspective StudiesSensitivity and SpecificitySex FactorsSymptom AssessmentAutism spectrum disorderConcordanceDSM-5SensitivitySpecificity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.